Skip to content

Psychedelic-assisted therapy: all studies

Page 37 of 294: studies 361 to 370 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis”. [J. Affect. Disord., 322 (2023), 194–204]

Journal of Affective Disorders January 5, 2024 Kwonmok Ko, Emma I Kopra, Anthony J. Cleare et al. 1 citation correction

The authors wish to express their regret regarding an error in the publication of the original article. In Table 3, titled “Psilocybin studies on depressive disorders,” specifically in the fourth row related to the study conducted by Carhart-Harris et al. (2016), the main results column inaccurately presented the Cohen's d figure, which included data from Carhart-Harris et al. (2018) that...

DOI: 10.1016/j.jad.2023.10.159 (opens in new tab) Anxiety Affect linguistics Clinical psychology Depressive symptoms +2

Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals.

Journal of Psychoactive Drugs 2024 Raymond Feng, Terence H. W. Ching, Amy Bartlett et al.

Psychedelic-assisted psychotherapy (PAP) is gaining renewed interest as a treatment for various mental disorders. However, there has been limited Black, Indigenous, and People of Color (BIPOC) representation in PAP clinical trials, signaling the need for culturally consonant communication about the efficacy and safety of PAP. We randomly assigned 321 BIPOC and 301 non-Hispanic White...

Ketamine-Assisted Psychotherapy: opportunities and challenges

Medical Research Archives 2024 Daniel Kleinloog

Ketamine is a dissociative anesthetic with unique pharmacological and psychological properties. Its antidepressant effects are mediated through the glutamatergic system and subsequent neuroplasticity and can be amplified when combined with psychotherapy. The ketamine-induced dissociative state should not be seen as an unwanted side-effect, but as a unique opportunity for psychotherapeutic...

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.

European Journal of Psychotraumatology 2024 Richard J. Zeifman, Hannes Kettner, Stephen Ross et al. 34 citations

Background: MDMA-assisted psychotherapy (MDMA-AP) is a combined psychotherapeutic and pharmacologic intervention that shows promise in the treatment of posttraumatic stress disorder (PTSD). Although therapeutic alliance has been established as a key predictor across psychotherapies and is emphasised within MDMA-AP treatment manuals, research has not yet examined the relationship between...

DOI: 10.1080/20008066.2023.2297536 (opens in new tab) Full text (opens in new tab) MDMA-Assisted Psychotherapy Posttraumatic stress disorder Alianza terapéutica Mecanismos de cambio +2

Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy.

Frontiers in Psychiatry 2024 Christopher P Harris, Becky Jones, Kathryn Walker et al. 4 citations

Evidence has increased in recent years regarding the potential for ketamine to serve as a novel treatment option for a range of conditions, particularly depression (unipolar and bipolar). However, research regarding ketamine as a potential therapeutic for Autism Spectrum Disorder (ASD) is lacking, despite high overlap with bipolar depression and theoretical foundations for its use. A...

DOI: 10.3389/fpsyt.2024.1322679 (opens in new tab) Full text (opens in new tab) Autism spectrum disorder Bipolar disorder Case report Ketamine assisted psychotherapy +6

Including Sexually and Gender Diverse Populations in 3,4-Methylenedioxymethamphetamine-Assisted Psychotherapy Trial Research.

LGBT health 2024 Ziad Saade, Brady D. Hanshaw, Alex S Keuroghlian 3 citations

Sexually and gender diverse (SGD) populations experience an increased prevalence and severity of posttraumatic stress disorder (PTSD) compared with the general population. Minority stress theory contextualizes this increased disease burden by outlining how stigma and discrimination (e.g., homophobia and transphobia) contribute to worse mental health outcomes. The standard-of-care...

Older adults in psychedelic-assisted therapy trials: A systematic review

Journal of Psychopharmacology 2024 Lisa Bouchet, Zachary Sager, Antoine Yrondi et al. 22 citations

Background: Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA) and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety,...

Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.

Neuropsychiatric Disease and Treatment 2024 Nadav Liam Modlin, Michael Creed, Maria Sarang et al. 18 citations

Post-traumatic stress disorder (PTSD) is associated with significant patient burden. While pharmacotherapies and evidence-based psychotherapy interventions (EBPI) are effective, studies consistently highlight inadequate outcomes and high treatment dropout. Psychedelic therapy (PT) has shown preliminary promise across difficult-to-treat conditions, including MDMA-assisted therapy for PTSD,...

[The nursing role in psychedelic-assisted psychotherapy].

Revue de l'infirmiere 2024 Caroline Amberger, Laurent Szczesniak

In this article, we aim to highlight the specific role of nurses in the interdisciplinary model of psychedelic-assisted psychotherapy. We argue that the plural competencies of our profession are at the heart of future issues in psychiatry and the use of psychedelics.